Amanote Research
Register
Sign In
OP0057 Fluorescence Optical Imaging in Juvenile Idiopathic Polyarticular Disease Before and During Antirheumatic Treatment
doi 10.1136/annrheumdis-2017-eular.2293
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2017
Authors
A Klein
G-W Just
SG Werner
I Becker
P Oommen
K Minden
H-E Langer
G Horneff
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism
Related search
Biological Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis of Polyarticular Course, Enthesitis-Related Arthritis, and Psoriatic Arthritis: A Consensus Statement
Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis
Polyarticular Juvenile Idiopathic Arthritis (pJIA): Clinical and Serologic Predictors of Inactive Disease (ID)
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Polyarticular Juvenile Idiopathic Arthritis &Ndash; Epidemiology and Management Approaches
Clinical Epidemiology
Epidemiology
Neutropenia During Tocilizumab Treatment Is Not Associated With Infection Risk in Systemic or Polyarticular-Course Juvenile Idiopathic Arthritis
Journal of Rheumatology
Rheumatology
Allergy
Immunology
7.4 Improvements in Individual Disease Components Are Sustained With Long-Term Adalimumab Therapy for Polyarticular Juvenile Idiopathic Arthritis
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Growth During Tocilizumab Therapy for Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From a Phase III Clinical Trial
Yearbook of Paediatric Endocrinology
Imaging in Juvenile Idiopathic Arthritis — International Initiatives and Ongoing Work
Pediatric Radiology
Nuclear Medicine
Radiology
Child Health
Perinatology
Imaging
Pediatrics
Renal Damage During Treatment With Antirheumatic Drugs.
BMJ
